Nanotherapeutics for the treatment of inflammatory bowel disease.

about

Nanotherapeutics for the treatment of inflammatory bowel disease.

Item

http://www.wikidata.org/entity/Q47941914

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Nanotherapeutics for the treatment of inflammatory bowel disease.

@en

Nanotherapeutics for the treatment of inflammatory bowel disease.

@nl

type

Item

label

Nanotherapeutics for the treatment of inflammatory bowel disease.

@en

Nanotherapeutics for the treatment of inflammatory bowel disease.

@nl

prefLabel

Nanotherapeutics for the treatment of inflammatory bowel disease.

@en

Nanotherapeutics for the treatment of inflammatory bowel disease.

@nl

P1476

Nanotherapeutics for the treatment of inflammatory bowel disease.

@en

P2093

Bo Xiao

http://www.w3.org/2001/XMLSchema#string

Didier Merlin

http://www.w3.org/2001/XMLSchema#string

Qiubing Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory Bowel Disease

Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target

Mesalazine in inflammatory bowel disease: a trendy topic once again?

Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.

Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease

Nanomedicine in GI

Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.

Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.

Intestinal epithelial CD98 directly modulates the innate host response to enteric bacterial pathogens.

Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy

P304

495-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1080/17474124.2017.1309282

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28317404

http://www.w3.org/2001/XMLSchema#string